Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy
Open Access
- 24 October 2025
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (43) , eadx5970
Abstract
The development of lipid nanoparticle (LNP) systems has largely advanced RNA therapeutics, particularly mRNA-based cancer immunotherapy. Conventional amine-LNPs, designed for hepatic RNA delivery, face challenges in targeting lymphoid organs effectively and maximize antigen presentation. In this study, we present the development of pH-responsive ionizable guanidine-LNPs (G-LNPs). Our cholesterol-free G-LNP system enables efficient delivery of mRNA to the spleen following intravenous administration. Notably, while both amine-LNPs and G-LNPs can deliver mRNA to the spleen, G-LNPs exhibit a unique ability to preferentially target antigen-presenting cells, leading to significantly enhanced antigen presentation and robust T cell activation. mRNA vaccines formulated with G-LNPs elicited strong and antigen-specific immune responses, providing complete protection against tumor progression. In addition, intraperitoneal administration of G-LNPs enabled selective mRNA expression in the pancreas, showcasing the versatility of this delivery platform. These findings underscore the potential of guanidine-LNPs as a highly promising platform for organ-targeted mRNA delivery and cancer immunotherapy.Keywords
This publication has 80 references indexed in Scilit:
- A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental AsthmaAdvanced Science, 2025
- Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic OrgansAdvanced Materials, 2024
- Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer ImmunotherapyAdvanced Materials, 2024
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA TransfectionAdvanced Materials, 2023
- Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell LymphomaAngewandte Chemie International Edition, 2023
- Therapeutic RNA Delivery for COVID and Other DiseasesAdvanced Healthcare Materials, 2021
- Use of an Octapeptide–Guanidiniocarbonylpyrrole Conjugate for the Formation of a Supramolecular β‐Helix that Self‐Assembles into pH‐Responsive FibersAngewandte Chemie International Edition, 2016
- Incorporation of a Non‐Natural Arginine Analogue into a Cyclic Peptide Leads to Formation of Positively Charged Nanofibers Capable of Gene TransfectionAngewandte Chemie International Edition, 2015
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012